Reference to Viscosupplementation and Biomatrix. Subject to applicable laws and regulations in the Territory, Wyeth shall ensure that all trade literature, publications and promotional materials relating to the Products and Extended Products produced by or on behalf of Wyeth or any of its Affiliates shall, in a reasonably conspicuous manner, refer to viscosupplementation. In major promotional materials, and other material where appropriate, Wyeth shall in a reasonably conspicuous manner reference that the concept and the name viscosupplementation have been conceived and introduced by the founders of Biomatrix. The product positioning for the Initial Product shall be the same as is currently used by Biomatrix, as redefined from time to time by *Confidential portions have been omitted and filed separately with the Commission. 18 -18- Biomatrix based upon current and new scientific, medical or marketing information obtained.
Appears in 2 contracts
Samples: International License Agreement (Biomatrix Inc), International License Agreement (Biomatrix Inc)
Reference to Viscosupplementation and Biomatrix. Subject to applicable laws and regulations in the Territory, Wyeth shall ensure that all trade literature, publications and promotional materials relating to the Products and Extended Products produced by or on behalf of Wyeth or any of its Affiliates shall, in a reasonably conspicuous manner, refer to viscosupplementation. In major promotional materials, and other material where appropriate, Wyeth shall shall, in a reasonably conspicuous manner manner, reference that the concept and the name viscosupplementation have been conceived and introduced by the founders of Biomatrix. The product positioning for the Initial Product shall be the same as is currently used by Biomatrix, as redefined from time to time by *Confidential portions have been omitted and filed separately with the Commission. 18 -18- Biomatrix based upon current and new scientific, medical or marketing information obtained.
Appears in 2 contracts
Samples: United States License Agreement (Biomatrix Inc), United States License Agreement (Biomatrix Inc)
Reference to Viscosupplementation and Biomatrix. Subject to applicable laws and regulations in the Territory, Wyeth shall ensure that all trade literature, publications and promotional materials relating to the Products and Extended Products produced by or on behalf of Wyeth or any of its Affiliates shall, in a reasonably conspicuous manner, refer to viscosupplementation. In major promotional materials, and other material where appropriate, Wyeth shall in a reasonably conspicuous manner reference that the concept and the name viscosupplementation have been conceived and introduced by the founders of Biomatrix. The product positioning for the Initial Product shall be the same as is currently used by Biomatrix, as redefined from time to time by *Confidential portions have been omitted and filed separately with the Commission. 18 -18- Biomatrix based upon current and new scientific, medical or marketing information obtained. *Confidential portions have been omitted and filed separately with the Commission.
Appears in 1 contract
Samples: License Agreement (Genzyme Corp)